Detalhe da pesquisa
1.
C9orf72 repeat length might influence clinical sub-phenotypes in dementia patients.
Neurobiol Dis
; 175: 105927, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36379394
2.
COVID-19-related delays of botulinum toxin injections have a negative impact on the quality of life of patients with dystonia and spasticity: a single-center ambulatory care study.
J Neural Transm (Vienna)
; 129(1): 49-53, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34689260
3.
CXCL13 as a biomarker in the diagnostics of European lyme Neuroborreliosis - A prospective multicentre study in Austria.
J Cent Nerv Syst Dis
; 16: 11795735241247026, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38706882
4.
Botulinum Toxin-A for the Treatment of Neuropathic Pain after Decompressive Craniotomy in Stroke: Two Cases.
Case Rep Neurol
; 15(1): 192-198, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37901125
5.
[Position paper of the Austrian Alzheimer Association (Österreichische Alzheimer Gesellschaft, ÖAG) : Effects of the COVID-19 pandemic in Austria on people with dementia and their care environment-problem areas, recommendations, and strategies]. / Positionspapier der Österreichische Alzheimer Gesellschaft (ÖAG) : Auswirkungen der COVID-19-Pandemie in Österreich auf Menschen mit Demenz und deren Betreuungsumfeld Problemfelder, Empfehlungen und Strategien.
Neuropsychiatr
; 35(1): 35-47, 2021 Mar.
Artigo
em Alemão
| MEDLINE | ID: mdl-33123943
6.
Management of mild cognitive impairment (MCI): The need for national and international guidelines.
World J Biol Psychiatry
; 21(8): 579-594, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32019392
7.
[Transdermal rivastigmine patch in outpatient services in Austria: a naturalistic study in 103 patients with Alzheimer dementia]. / Rivastigmin-Pflaster in der ambulanten Versorgung in Osterreich: eine naturalistische Studie an 103 PatientInnen mit Alzheimer Demenz.
Neuropsychiatr
; 23(1): 58-63, 2009.
Artigo
em Alemão
| MEDLINE | ID: mdl-19272293
8.
[Therapy of Alzheimer's disease: current status and future development]. / Therapie der Alzheimer Demenz: derzeitiger Stand und zukünftige Entwicklung.
Neuropsychiatr
; 22(3): 153-71, 2008.
Artigo
em Alemão
| MEDLINE | ID: mdl-18826870
9.
[Dementia with Lewy Bodies and its differentiation from Alzheimer's disease]. / Lewy-Körper-Demenz und ihre ifferentialdiagnostische Abgrenzung von Alzheimer'scher Erkrankung.
Neuropsychiatr
; 21(2): 63-74, 2007.
Artigo
em Alemão
| MEDLINE | ID: mdl-17640492
10.
In honor of the 80th birthday of Kurt Jellinger: a living legend in neuropathology.
Acta Neuropathol
; 121(5): 565-8, 2011 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-21523431
11.
Prevention of poststroke cognitive decline: ASPIS--a multicenter, randomized, observer-blind, parallel group clinical trial to evaluate multiple lifestyle interventions--study design and baseline characteristics.
Int J Stroke
; 10(4): 627-35, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-24206541
12.
Cognition, gender, and functional abilities in Alzheimer's disease: how are they related?
J Alzheimers Dis
; 35(2): 247-52, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23388173
13.
Driving cessation and dementia: results of the prospective registry on dementia in Austria (PRODEM).
PLoS One
; 7(12): e52710, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-23300746
14.
A novel LRRK2 mutation in an Austrian cohort of patients with Parkinson's disease.
Mov Disord
; 22(11): 1640-3, 2007 Aug 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-17523199
15.
From counting neurons to the preclinical diagnosis of Alzheimer's disease.
J Alzheimers Dis
; 3(1): 59-63, 2001 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-12214073